Lixte Biotechnology Holdings Inc LIXTW:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
1.21quote price arrow up+0.06 (+5.28%)
Volume
645
Close
1.15quote price arrow up+0.25 (+27.69%)
Volume
279,575
52 week range
0.65 - 6.77

...

Loading . . .

KEY STATS

  • Open2.00
  • Day High2.00
  • Day Low1.08
  • Prev Close0.90
  • 52 Week High6.77
  • 52 Week High Date11/27/20
  • 52 Week Low0.65
  • 52 Week Low Date11/25/20
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Lixte Biotechnology Holdings Inc News

There is no recent news for this security.

Latest LIXTW News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Lixte Biotechnology Holdings, Inc. is a drug discovery company. The Company uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. It's product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers, and includes two categories of compounds at various stages of pre-clinical...
John Kovach
President
Robert Weingarten
Chief Financial Officer
Address
248 Route 25A, No. 2
East Setauket, NY
11733
United States